The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | BBG01JLQNZ03 | 60,570,547 | 713,434 | SH | SOLE | 713,434 | 0 | 0 | ||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | BBG01H51WYQ5 | 81,392,745 | 2,048,647 | SH | SOLE | 2,048,647 | 0 | 0 | ||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | BBG000QSGWX5 | 25,874,059 | 3,554,129 | SH | SOLE | 3,554,129 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | BBG00B6G7GL7 | 99,003,125 | 815,176 | SH | SOLE | 815,176 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | BBG007DHZQR7 | 129,289,082 | 9,003,418 | SH | SOLE | 9,003,418 | 0 | 0 | ||
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | BBG001J1BQN9 | 16,501,727 | 1,387,866 | SH | SOLE | 1,387,866 | 0 | 0 | ||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | BBG00FB2NPZ0 | 130,137,966 | 3,307,191 | SH | SOLE | 3,307,191 | 0 | 0 | ||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | BBG00CP3BDD4 | 75,973,259 | 3,711,444 | SH | SOLE | 3,711,444 | 0 | 0 | ||
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | BBG005TP2339 | 9,922,500 | 6,125,000 | SH | SOLE | 6,125,000 | 0 | 0 | ||
| JADE BIOSCIENCES INC | COM NEW | 008064206 | BBG00WGHZFH4 | 27,791,776 | 3,220,368 | SH | SOLE | 3,220,368 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | BBG00KT2KFX7 | 68,839,338 | 1,772,839 | SH | SOLE | 1,772,839 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | BBG00Z1SLMK5 | 62,919,648 | 727,563 | SH | SOLE | 727,563 | 0 | 0 | ||
| ORUKA THERAPEUTICS INC | COM | 687604108 | BBG000BWNN28 | 71,252,188 | 3,705,262 | SH | SOLE | 3,705,262 | 0 | 0 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | BBG00KT2RRM6 | 67,926,914 | 1,824,031 | SH | SOLE | 1,824,031 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | BBG0067L94B2 | 67,343,373 | 4,018,101 | SH | SOLE | 4,018,101 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG002H242Z5 | 74,664,923 | 3,459,913 | SH | SOLE | 3,459,913 | 0 | 0 | ||
| ZENAS BIOPHARMA INC | COM | 98937L105 | BBG01J1MG9D6 | 42,020,293 | 1,892,806 | SH | SOLE | 1,892,806 | 0 | 0 | ||